Cargando…

Redox-Active Metal Ions and Amyloid-Degrading Enzymes in Alzheimer’s Disease

Redox-active metal ions, Cu(I/II) and Fe(II/III), are essential biological molecules for the normal functioning of the brain, including oxidative metabolism, synaptic plasticity, myelination, and generation of neurotransmitters. Dyshomeostasis of these redox-active metal ions in the brain could caus...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Namdoo, Lee, Hyuck Jin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307724/ https://www.ncbi.nlm.nih.gov/pubmed/34299316 http://dx.doi.org/10.3390/ijms22147697

Ejemplares similares

Target Enzymes Considered for the Treatment of Alzheimer's Disease and Parkinson's Disease
por: Kim, Namdoo, et al.
Publicado: (2020)

Metal Complexes as Promising Matrix Metalloproteinases Regulators
por: Nguyen, Yen Thi, et al.
Publicado: (2023)

β-Amyloid Degradation and Alzheimer's Disease
por: Wang, Deng-Shun, et al.
Publicado: (2006)

Effect of metal ions on Alzheimer's disease
por: Liu, Fan, et al.
Publicado: (2022)

The Potential Roles of Redox Enzymes in Alzheimer’s Disease: Focus on Thioredoxin
por: Jia, Jinjing, et al.
Publicado: (2021)

The amyloid beta ion channel hypothesis of Alzheimer’s disease
por: Shirwany, Najeeb A, et al.
Publicado: (2007)

Hypothesis: Soluble Aβ Oligomers in Association with Redox-Active Metal Ions Are the Optimal Generators of Reactive Oxygen Species in Alzheimer's Disease
por: Tabner, Brian J., et al.
Publicado: (2010)

Redox Regulation of Insulin Degradation by Insulin-Degrading Enzyme
por: Cordes, Crystal M., et al.
Publicado: (2011)

Metal ions and redox balance regulate distinct amyloid-like aggregation pathways of GAPR-1
por: Sheng, Jie, et al.
Publicado: (2019)

Redox Active Transition Metal ions Make Melanin Susceptible to Chemical Degradation Induced by Organic Peroxide
por: Zadlo, Andrzej, et al.
Publicado: (2017)

Impaired hepatic amyloid-beta degradation in Alzheimer’s disease
por: Maarouf, Chera L., et al.
Publicado: (2018)

Current understanding of metal ions in the pathogenesis of Alzheimer’s disease
por: Wang, Lu, et al.
Publicado: (2020)

A rationally designed small molecule for identifying an in vivo link between metal–amyloid-β complexes and the pathogenesis of Alzheimer's disease
por: Beck, Michael W., et al.
Publicado: (2015)

The core sequence of PIF competes for insulin/amyloid β in insulin degrading enzyme: potential treatment for Alzheimer's disease
por: Hayrabedyan, Soren, et al.
Publicado: (2018)

Regulatory feedback cycle of the insulin‐degrading enzyme and the amyloid precursor protein intracellular domain: Implications for Alzheimer’s disease
por: Lauer, Anna A., et al.
Publicado: (2020)

Aβ and Tau Interact with Metal Ions, Lipid Membranes and Peptide-Based Amyloid Inhibitors: Are These Common Features Relevant in Alzheimer’s Disease?
por: Di Natale, Giuseppe, et al.
Publicado: (2022)

The Alzheimer's Amyloid-Degrading Peptidase, Neprilysin: Can We Control It?
por: Nalivaeva, N. N., et al.
Publicado: (2012)

Redox and trace metal regulation of ion channels in the pain pathway
por: Evans, J. Grayson, et al.
Publicado: (2015)

Redox‐Flow Batteries: From Metals to Organic Redox‐Active Materials
por: Winsberg, Jan, et al.
Publicado: (2016)

Lipid rafts participate in aberrant degradative autophagic-lysosomal pathway of amyloid-beta peptide in Alzheimer's disease
por: Zhou, Xin, et al.
Publicado: (2014)

Anti-Amyloid Therapies for Alzheimer’s Disease and the Amyloid Cascade Hypothesis
por: Fedele, Ernesto
Publicado: (2023)

Fasting activates macroautophagy in neurons of Alzheimer’s disease mouse model but is insufficient to degrade amyloid-beta
por: Chen, Xigui, et al.
Publicado: (2015)

The Amyloid-β Pathway in Alzheimer’s Disease
por: Hampel, Harald, et al.
Publicado: (2021)

Amyloid Beta in Aging and Alzheimer’s Disease
por: Sehar, Ujala, et al.
Publicado: (2022)

Amyloid Precursor Protein and Alzheimer’s Disease
por: Orobets, Kseniia S., et al.
Publicado: (2023)

Recent Development of Bifunctional Small Molecules to Study Metal-Amyloid-β Species in Alzheimer's Disease
por: Braymer, Joseph J., et al.
Publicado: (2010)

Diagnosis of Alzheimer’s disease utilizing amyloid and tau as fluid biomarkers
por: Lee, Jinny Claire, et al.
Publicado: (2019)

Increase of Redox Potential during the Evolution of Enzymes Degrading Recalcitrant Lignin
por: Ayuso‐Fernández, Iván, et al.
Publicado: (2019)

Natural Products Targeting Amyloid Beta in Alzheimer’s Disease
por: Lee, Joo-Hee, et al.
Publicado: (2021)

A computational study of metal ions interaction with amyloid-β 1–42 peptide structure in hyperpyrexia: Implications for Alzheimer disease
por: Mocanu, Cosmin Stefan, et al.
Publicado: (2022)

Redox control of protein degradation
por: Pajares, Marta, et al.
Publicado: (2015)

Mitochondria, Amyloid β, and Alzheimer's Disease
por: Readnower, Ryan D., et al.
Publicado: (2011)

Effects of Redox Homeostasis and Mitochondrial Damage on Alzheimer’s Disease
por: Wu, Yi-Hsuan, et al.
Publicado: (2023)

Impact of sphingosine and acetylsphingosines on the aggregation and toxicity of metal-free and metal-treated amyloid-β
por: Yi, Yelim, et al.
Publicado: (2020)

Technical aspects of amyloid imaging for Alzheimer's disease
por: Edison, Paul, et al.
Publicado: (2011)

Amyloid β-protein oligomers and Alzheimer’s disease
por: Hayden, Eric Y, et al.
Publicado: (2013)

The role of astrocytes in amyloid production and Alzheimer's disease
por: Frost, Georgia R., et al.
Publicado: (2017)

The amyloid hypothesis of Alzheimer's disease at 25 years
por: Selkoe, Dennis J, et al.
Publicado: (2016)

Critical analysis of the use of β-site amyloid precursor protein-cleaving enzyme 1 inhibitors in the treatment of Alzheimer’s disease
por: Evin, Genevieve, et al.
Publicado: (2014)

Metals in Alzheimer’s Disease
por: Babić Leko, Mirjana, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ec5ra3k38lnde85d2l6mk3mvt7